Home/Investors/Northpond Ventures

Northpond Ventures

Biotech Investor · 2 portfolio companies

Portfolio

2

Combined Value

$259.5M

Focus Areas

7

Top Stage

Pre-clinical

Investment Focus

Neurology Metabolic Disorders Rare Diseases Antibody Discovery Cell & Gene Therapy Vaccine Development Synthetic Biology

Portfolio Companies

Company	Stage	Valuation	Focus
CAMP4 Therapeutics	Pre-clinical	$259.4M	Neurology, Metabolic Disorders
Telesis Bio	Commercial	$98K	Antibody Discovery, Cell & Gene Therapy

Frequent Co-Investors

Fidelity Management & Research Company1 shared Polaris Partners1 shared 5AM Ventures1 shared Andreessen Horowitz Bio + Health1 shared Arrowmark Partners1 shared Claris Ventures1 shared Novalis LifeSciences1 shared